MARKETSBiocon Hits 52-Week High After USFDA Nod for Key Diabetes Drug, Shares Up 1%Dhruva KulkarniJuly 16, 2025July 16, 2025 July 16, 2025July 16, 2025 Shares of Biocon Ltd rose 1% to touch a day’s high of Rs 405.90 on 16th July, after the United States Food & Drug Administration...
MARKETSBiocon Gains 1% After India Nod for Diabetes Drug LiraglutideDhruva KulkarniJune 3, 2025June 3, 2025 June 3, 2025June 3, 2025 Shares of Biocon Ltd rose 1% to touch a day’s high of Rs 340 on 3rd June. This increase came after the company announced it...
WORLDBiocon, Viatris Receive EC Nod For Biosimilar BevacizumabadminApril 26, 2021April 26, 2021 April 26, 2021April 26, 2021 Biocon Biologics Ltd, a subsidiary of Bengaluru-headquartered Biocon Ltd, has announced that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc.,...